CKD Bio Corp.

KOSE:A063160 株式レポート

時価総額：₩116.3b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

CKD Bio マネジメント

マネジメント 基準チェック /04

現在、CEO に関する十分な情報がありません。

主要情報

Hui Kang

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間no data
CEOの所有権n/a
経営陣の平均在職期間データなし
取締役会の平均在任期間データなし

経営陣の近況

Recent updates

What You Need To Know About CKD Bio Corp.'s (KRX:063160) Investor Composition

Feb 28
What You Need To Know About CKD Bio Corp.'s (KRX:063160) Investor Composition

Is CKD Bio's (KRX:063160) 203% Share Price Increase Well Justified?

Feb 01
Is CKD Bio's (KRX:063160) 203% Share Price Increase Well Justified?

CKD Bio (KRX:063160) Takes On Some Risk With Its Use Of Debt

Jan 11
CKD Bio (KRX:063160) Takes On Some Risk With Its Use Of Debt

What CKD Bio Corp.'s (KRX:063160) ROE Can Tell Us

Dec 21
What CKD Bio Corp.'s (KRX:063160) ROE Can Tell Us

Here's Why We Don't Think CKD Bio's (KRX:063160) Statutory Earnings Reflect Its Underlying Earnings Potential

Nov 30
Here's Why We Don't Think CKD Bio's (KRX:063160) Statutory Earnings Reflect Its Underlying Earnings Potential

CEO（最高経営責任者

Hui Kang

no data

在職期間

Mr. Hui Yil Kang serves as a Co-Chief Executive Officer, Vice President, and Director of Ckd Bio Corporation.